Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Cromwell Prop (CMW AU): ESR Exit Post-Privatization?

ESR Cayman (1821 HK) Takes Out ARA Asset Management

Quiddity Advisors

Event-Driven

<ul>
<li>Back on the 13th May 2024, <strong><a href="https://www.smartkarma.com/entities/esr-group-ltd" target="_blank" data-smartkarma-citation="entities:27983:1" rel="noopener">ESR Group (1821 HK)</a></strong> announced a <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0513/2024051300798.pdf" target="_blank" rel="noopener">delisting proposal</a> from a consortium of investors formed by Starwood Capital Operations, Sixth Street Partners, and SSW Partners.</li>
<li>The consortium initially controlled 15.7%. Warburg (~14%) and ESR founders (~7.4%) tipped in their stakes. As did Qatar (3%) <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1004/2024100401641.pdf" target="_blank" rel="noopener">earlier this month</a>, bringing the collective total to 39.9%.</li>
<li>No terms have been made public. Yesterday a Bloomberg article flagging "<em>an agreement also might not be reached</em>" saw shares freefall. Plus Capital Group recently trimmed its stake.</li>
</ul>


Back on the 13th May 2024, ESR Group (1821 HK) announced a delisting proposal from a consortium of investors formed by Starwood Capital Operations, Sixth Street Partners, and SSW Partners.
The consortium initially controlled 15.7%. Warburg (~14%) and ESR founders (~7.4%) tipped in their stakes. As did Qatar (3%) earlier this month, bringing the collective total to 39.9%.
No terms have been made public. Yesterday a Bloomberg article flagging "an agreement also might not be reached" saw shares freefall. Plus Capital Group recently trimmed its stake.


China Traditional Chinese Medicine (570 HK)

ESR (1821 HK): Sell First, Ask Questions Later